Edwards Lifesciences EW Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Europe | $439.6M+16.2% | $442.6M+29.5% | $409.6M+15.9% | $387.9M+23.1% | $378.2M+12.9% | |
| Japan | $96.4M+1.2% | $90.6M+10.8% | $87.5M+17.9% | $90.1M+5.0% | $95.3M+2.3% | |
| Rest of World | $201.5M+19.2% | $177.8M+18.4% | $165.5M+26.2% | $167.6M+9.4% | $169M+12.1% | |
| United States | $1B+12.8% | $937.6M+11.8% | $907M+11.6% | $907.5M+12.8% | $889.7M+8.9% | |
| Net Sales by Product | ||||||
| Surgical | $284.1M— | $276.2M+10.1% | —— | —— | —— | |
| Transcatheter Aortic Valve Replacement | $1.26B+11.3% | $1.2B+14.4% | $1.16B+12.0% | $1.15B+12.4% | $1.13B+8.9% | |
| Transcatheter Mitral and Tricuspid Therapies | $198.6M+47.7% | $175.1M+52.0% | $155.7M+48.1% | $145.2M+59.4% | $134.5M+62.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Edwards Lifesciences break its business down?
- Edwards Lifesciences (EW) reports net sales by business across 4 parts — Europe, Japan, Rest of World and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Edwards Lifesciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Edwards Lifesciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
